Climb Bio (CLYM) Accounts Payables (2020 - 2026)
Climb Bio (CLYM) posted Accounts Payables of $860000.0 for Q1 2026, down 62.1% on a QoQ basis from $2.3 million in Q4 2025, and up 10.68% year-over-year from $777000.0 in Q1 2025.
Climb Bio (CLYM) Accounts Payables (2020 - 2026) Analysis & Trends
Climb Bio's Accounts Payables history runs 7 years deep, the most recent figure standing at $860000.0 for Q1 2026.
- Quarterly Accounts Payables rose 10.68% year-over-year to $860000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $860000.0 (up 10.68% YoY) and the FY2025 annual result came in at $2.3 million, up 221.84% from the prior year.
- Accounts Payables was $860000.0 for Q1 2026 at Climb Bio, down from $2.3 million in the prior quarter.
- Across five years, Accounts Payables topped out at $2.3 million in Q4 2025 and bottomed at $66000.0 in Q4 2023.
- A 5-year average of $800882.4 and a median of $777000.0 in 2025 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2022 — Accounts Payables jumped 4568.75% — and 2023, when it plunged 91.2%.
- Climb Bio's Accounts Payables stood at $750000.0 in 2022, then plunged by 91.2% to $66000.0 in 2023, then jumped by 968.18% to $705000.0 in 2024, then soared by 221.84% to $2.3 million in 2025, then tumbled by 62.1% to $860000.0 in 2026.
- Business Quant data shows CLYM's Accounts Payables at $860000.0 in Q1 2026, $2.3 million in Q4 2025, and $477000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Climb Bio | 870.33 Mn | 870.33 Mn | - | 860,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 860,000.00 |
| Dec 31, 2025 | 2.27 Mn |
| Sep 30, 2025 | 477,000.00 |
| Jun 30, 2025 | 946,000.00 |
| Mar 31, 2025 | 777,000.00 |
| Dec 31, 2024 | 705,000.00 |
| Sep 30, 2024 | 291,000.00 |
| Jun 30, 2024 | 509,000.00 |
| Mar 31, 2024 | 85,000.00 |
| Dec 31, 2023 | 66,000.00 |
| Sep 30, 2023 | 736,000.00 |
| Jun 30, 2023 | 878,000.00 |
| Mar 31, 2023 | 864,000.00 |
| Dec 31, 2022 | 750,000.00 |
| Sep 30, 2022 | 1.49 Mn |
| Jun 30, 2022 | 1.06 Mn |
| Mar 31, 2022 | 847,000.00 |
| Dec 31, 2021 | 1.40 Mn |
| Sep 30, 2021 | 32,000.00 |
| Jun 30, 2021 | 127,000.00 |